Association between hyperglycaemic crisis and long-term major adverse cardiovascular events: a nationwide population-based, propensity score-matched, cohort study. 2016

Li-Hsin Chang, and Liang-Yu Lin, and Ming-Tsun Tsai, and Chorng-Kuang How, and Jen-Huai Chiang, and Vivian Chia-Rong Hsieh, and Sung-Yuan Hu, and Ming-Shun Hsieh
Division of Endocrinology and Metabolism, Department of Internal Medicine, Taipei Veterans General Hospital, Taoyuan Branch, Taoyuan, Taiwan School of Medicine, National Yang-Ming University, Taipei, Taiwan.

Hyperglycaemic crisis was associated with significant intrahospital morbidity and mortality. However, the association between hyperglycaemic crisis and long-term cardiovascular outcomes remained unknown. This study aimed to investigate the association between hyperglycaemic crisis and subsequent long-term major adverse cardiovascular events (MACEs). This population-based cohort study was conducted using data from Taiwan's National Health Insurance Research Database for the period of 1996-2012. A total of 2171 diabetic patients with hyperglycaemic crisis fit the inclusion criteria. Propensity score matching was used to match the baseline characteristics of the study cohort to construct a comparison cohort which comprised 8684 diabetic patients without hyperglycaemic crisis. The risk of long-term MACEs was compared between the two cohorts. Six hundred and seventy-six MACEs occurred in the study cohort and the event rate was higher than that in the comparison cohort (31.1% vs 24.1%, p<0.001). Patients with hyperglycaemic crisis were associated with a higher risk of long-term MACEs even after adjusting for all baseline characteristics and medications (adjusted HR=1.76, 95% CI 1.62 to 1.92, p<0.001). Acute myocardial infarction had the highest adjusted HR (adjusted HR=2.19, 95% CI 1.75 to 2.75, p<0.001) in the four types of MACEs, followed by congestive heart failure (adjusted HR=1.97, 95% CI 1.70 to 2.28, p<0.001). Younger patients with hyperglycaemic crisis had a higher risk of MACEs than older patients (adjusted HR=2.69 for patients aged 20-39 years vs adjusted HR=1.58 for patients aged >65 years). Hyperglycaemic crisis was significantly associated with long-term MACEs, especially in the young population. Further prospective longitudinal study should be conducted for validation.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002318 Cardiovascular Diseases Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM. Adverse Cardiac Event,Cardiac Events,Major Adverse Cardiac Events,Adverse Cardiac Events,Cardiac Event,Cardiac Event, Adverse,Cardiac Events, Adverse,Cardiovascular Disease,Disease, Cardiovascular,Event, Cardiac
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006943 Hyperglycemia Abnormally high BLOOD GLUCOSE level. Postprandial Hyperglycemia,Hyperglycemia, Postprandial,Hyperglycemias,Hyperglycemias, Postprandial,Postprandial Hyperglycemias
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000367 Age Factors Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time. Age Reporting,Age Factor,Factor, Age,Factors, Age
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

Li-Hsin Chang, and Liang-Yu Lin, and Ming-Tsun Tsai, and Chorng-Kuang How, and Jen-Huai Chiang, and Vivian Chia-Rong Hsieh, and Sung-Yuan Hu, and Ming-Shun Hsieh
September 2016, BMJ open,
Li-Hsin Chang, and Liang-Yu Lin, and Ming-Tsun Tsai, and Chorng-Kuang How, and Jen-Huai Chiang, and Vivian Chia-Rong Hsieh, and Sung-Yuan Hu, and Ming-Shun Hsieh
July 2016, American journal of respiratory and critical care medicine,
Li-Hsin Chang, and Liang-Yu Lin, and Ming-Tsun Tsai, and Chorng-Kuang How, and Jen-Huai Chiang, and Vivian Chia-Rong Hsieh, and Sung-Yuan Hu, and Ming-Shun Hsieh
March 2020, Cancers,
Li-Hsin Chang, and Liang-Yu Lin, and Ming-Tsun Tsai, and Chorng-Kuang How, and Jen-Huai Chiang, and Vivian Chia-Rong Hsieh, and Sung-Yuan Hu, and Ming-Shun Hsieh
June 2023, Journal of the European Academy of Dermatology and Venereology : JEADV,
Li-Hsin Chang, and Liang-Yu Lin, and Ming-Tsun Tsai, and Chorng-Kuang How, and Jen-Huai Chiang, and Vivian Chia-Rong Hsieh, and Sung-Yuan Hu, and Ming-Shun Hsieh
January 2015, PloS one,
Li-Hsin Chang, and Liang-Yu Lin, and Ming-Tsun Tsai, and Chorng-Kuang How, and Jen-Huai Chiang, and Vivian Chia-Rong Hsieh, and Sung-Yuan Hu, and Ming-Shun Hsieh
May 2024, Esophagus : official journal of the Japan Esophageal Society,
Li-Hsin Chang, and Liang-Yu Lin, and Ming-Tsun Tsai, and Chorng-Kuang How, and Jen-Huai Chiang, and Vivian Chia-Rong Hsieh, and Sung-Yuan Hu, and Ming-Shun Hsieh
February 2022, European heart journal. Cardiovascular pharmacotherapy,
Li-Hsin Chang, and Liang-Yu Lin, and Ming-Tsun Tsai, and Chorng-Kuang How, and Jen-Huai Chiang, and Vivian Chia-Rong Hsieh, and Sung-Yuan Hu, and Ming-Shun Hsieh
June 2021, International journal of environmental research and public health,
Li-Hsin Chang, and Liang-Yu Lin, and Ming-Tsun Tsai, and Chorng-Kuang How, and Jen-Huai Chiang, and Vivian Chia-Rong Hsieh, and Sung-Yuan Hu, and Ming-Shun Hsieh
March 2024, Targeted oncology,
Li-Hsin Chang, and Liang-Yu Lin, and Ming-Tsun Tsai, and Chorng-Kuang How, and Jen-Huai Chiang, and Vivian Chia-Rong Hsieh, and Sung-Yuan Hu, and Ming-Shun Hsieh
March 2023, Kidney research and clinical practice,
Copied contents to your clipboard!